Cardiex specializes in the development of biomarkers and digital solutions for large-scale cardiovascular health disorders
Our Solutions
Our solutions are designed to be deployed at point-of-care for arterial health screening, and as part of a remote patient monitoring regimen to extend care and improve cardiovascular health outcomes.
For Providers
Enable physicians to make more informed treatment decisions based on clinically relevant vascular health data.
For Clinical Trials
Generate reliable, real-world, clinically relevant data to accelerate drug development and commercialization.
For Researchers
Digital vascular biomarkers accelerate a researcher’s understanding of vascular health.
For Patients
Empower individuals with vascular health insights to actively participate in their health journey.
Dr. Joseph Raffaele
Longevity Medicine Specialist
Utilizing digital biomarkers to improve cardiovascular health of patients
Our FDA-cleared technology replaces traditional blood pressure technology as the first-line screening and monitoring of arterial health.
Risk Stratification: Evaluate arterial health and identify those who may be at greater risk of cardiovascular, metabolic, renal, and neurological diseases.
Early Detection of Disease Onset: Stiffening of arteries are an early indicator of disease onset.
Monitoring Progression: Regular assessments track changes over time to signal improvement or worsening disease progression.
Treatment Evaluation: Assess the efficacy of pharmacological and lifestyle interventions.
CARTESIAN Study
Artery Society
CARTESIAN aims to explore the immediate and long-term vascular consequences of COVID-19. Our SphygmoCor® XCEL was selected to assess subjects' arterial stiffness and central pressure hemodynamics.
There is no greater health mission than prioritizing arterial wellness—because a world with healthy arteries is a world with boundless potential for life and vitality.
— Craig R. Cooper
Get Monthly Insights to your Inbox
Clinical Trial & Research Partners
